Newton's Tree

Missed the live event? Catch up with the insightful conversation with Keith Grimes, MD of Curistica, as he shares his journey from a tech-inspired GP to clinical leadership at Babylon Health and now supports digital innovators in healthcare, and Haris Shuaib, CEO of Newton's Tree. Topics covered include: ➡️ The challenges of bringing AI-driven healthcare solutions to market ➡️ What good leadership looks like ➡️ Practical advice for healthcare professionals on how they can get involved in healthcare AI Watch the full interview here: https://lnkd.in/eCh4cFT3

Great to be part of a publication in The Lancet Digital Health. We explored the use of synthetic data in health. 🔹 Synthetic data will never replace the need for real data. 🔹 However there is utility, such as improving how robust an AI model is. 🔹 But personal data can emerge amongst datasets, or datasets can be used unethically. 🔹 So, appropriate standards must be developed. Thank you for bringing me into this Anmol Arora , Siegfried Wagner , Rajesh Jena , and Pearse Keane.

🌟 Join us tomorrow, Thursday, 12 December (12:30–1:30pm) for an Unfiltered AI Leadership webinar with Keith Grimes, Founder of Curistica, and a leading voice in Digital Health, and hosted by Haris Shuaib, CEO of Newton's Tree. Don’t miss this engaging conversation + live Q&A on the future of medical AI.

Are you at GIANT Health Event today, Tuesday 10th December? Make sure to join the 14:30 panel on 'The Trouble with AI in Healthcare'. This session looks at bias in AI, liability concerns around AI errors, and the ethical considerations of AI in healthcare, all grounded in real healthcare examples. Chairing the panel we have Dr Hugh Harvey from Hardian Health, with Nell Thornton from The Health Foundation, Rachel Power from The Patients Association, and our very own Haris Shuaib of Newton's Tree and NHS Fellowship in Clinical AI. The event is free for NHS Staff. Looking forward to seeing you there. #GIANT2024

Newton’s Tree has been included in the Department for Science, Innovation and Technology AI Assurance Techniques Portfolio. The initiative supports organisations across the AI lifecycle by providing appropriate techniques for trustworthy AI. Newton’s Tree Federated AI Monitoring Service (FAMOS) has been included as a way of detecting drift, which is key to ensure AI that starts safe, stays safe. FAMOS has also recently been announced as part of the Medicines and Healthcare products Regulatory Agency AI Airlock.

🎙️ Don't miss our next unfiltered AI leadership conversation webinar this Thursday, hosted by Haris Shuaib with guest Keith Grimes, a GP, Digital Health and Innovation Consultant, and founder of Curistica. Join us for an engaging live conversation, followed by an interactive Q&A where you’ll have the chance to ask your pressing questions about medical AI. Keith brings unparalleled expertise, having contributed to the Topol Review, the AI All Party Parliamentary Group, and lecturing at leading universities on Generative AI in Healthcare, Digital Health, and Entrepreneurship.

📣 Update on our pilot scheme, AI Airlock We have selected 5️⃣ technologies for the AI Airlock, a pilot scheme to better understand how we can regulate artificial intelligence (AI) powered medical devices in a way that that enables getting these types of products to the NHS and patients who need them as quickly and safely as possible. 💡 These novel medical devices have the potential to significantly improve the diagnosis and care of patients. Those selected for the pilot include medical devices for cancer and chronic respiratory disease patients as well as those requiring radiology diagnostic services. Before any medical product can reach patients, there must be evidence to show that it is safe and that it works when used for its intended purpose outside of a study setting. New AI technology makes it challenging to generate this evidence for a number of reasons, including the fact that the medical device changes as it learns. 🔁 In case you need a refresher: AI Airlock is a regulatory “sandbox”, a type of study where manufacturers can explore how best to collect evidence that could later be used to support the approval of their product. This is done under MHRA supervision in a virtual or simulated setting. Doing so will help the manufacturer and the MHRA better understand the challenges of regulating AI in medical devices, leading to a more bespoke and enabling regulatory framework, a clearer route to market for industry and, most importantly, paving the way for quicker NHS and patient access to potentially transformative AI technologies. Our MedTech Regulatory Reform Lead and Chief Officer at the MHRA, Laura Squire OBE, said: “New AI medical devices have the potential to increase the accuracy of healthcare decisions, save time and improve efficiency, leading to better outcomes for the NHS and patients across all healthcare settings. “But we need to be confident that AI-powered medical devices introduced into the NHS are safe, and stay safe and perform as intended through their lifetime of use. “By examining the technologies announced today in a safe setting, in partnership with technology specialists, developers and the NHS, we can test and improve the rules for AI-powered medical devices, helping get products like these to the hospitals and patients who need them sooner.” To read the full announcement, visit ➡️ https://bit.ly/3CTrcfW

Newton’s Tree has been selected for the prestigious MHRA AI Airlock Programme. This groundbreaking regulatory sandbox, developed by the Medicines and Healthcare products Regulatory Agency in partnership with Department of Health and Social Care NHS AI Lab, is tackling key challenges in the safe deployment of AI as a Medical Device and completes in March 2025. We will further develop our Federated AI Monitoring Service (FAMOS), a key component of the Newton's Tree platform. FAMOS gives hospitals, AI developers, and regulators the ability to observe and monitor AI performance in near real time, which helps them to tackle the challenge of drift; where changes in clinical environments, input data or human-computer interactions can degrade AI performance. As the UK accelerates its uptake of healthcare AI, FAMOS supports better risk management and enhances patient safety in healthcare AI by ensuring AI remains safe and effective post-deployment. We're collaborating with leading partners including Leeds Teaching Hospitals NHS Trust NHS Greater Glasgow and Clyde, Annalise.ai, Infervision, Qure.ai, Vita Healthcare Solutions, Imperial College London, NVIDIA. Get in touch if you want to know more about how we can help organisations use AI effectively and safely. 📧 info@newtonstree.com

We're excited to invite you to join the next unfiltered AI leadership conversation webinar, hosted by Haris Shuaib with guest Dr. Keith Grimes, a GP, Digital Health and Innovation Consultant, and founder of Curistica. Keith brings unparalleled expertise, having contributed to the Topol Review, the AI All Party Parliamentary Group, and lecturing at leading universities on Generative AI in Healthcare, Digital Health, and Entrepreneurship. 🗓️ Thursday 12 December ⏰ 12.30PM-1.30PM 🗨️ Zoom 👉 https://lnkd.in/ePuSgW28 Join us for an engaging live conversation, followed by an interactive Q&A where you’ll have the chance to ask your pressing questions about medical AI.

Hexarad and Newton’s Tree form partnership to transform how hospitals access AI. The partnership will combine Hexarad’s technology-enabled teleradiology and proprietary software platform with Newton's Tree’s vendor-neutral AI platform to reduce NHS radiology departments’ reliance on manual processes and enable them to trial, adopt and evaluate AI tools more easily. https://lnkd.in/e9FrJcwF #RADMagazine #medicalimaging #news #healthcare #medical #radiology #AI